We are international
Donate
TEXT SIZE   
back

The IMF Visits Jordan’s Renowned Cancer Center

On May 6th, the IMF's Director of Europe and the Middle East, Nadia Elkebir, visited the King Hussein Cancer Center (KHCC) in Amman, Jordan. This renowned stand-alone comprehensive cancer center attracts patients from all over the Middle East, the Gulf region, and North Africa. The IMF will work in partnership with KHCC to reach myeloma patients throughout the region.

05.14.14

Last week, the IMF continued expanding its outreach to myeloma patients and healthcare professionals around the world. 

On May 6th, the IMF’s Director of Europe and the Middle East, Nadia Elkebir, visited the King Hussein Cancer Center (KHCC) in Amman, Jordan.

This renowned stand-alone comprehensive cancer center attracts patients from all over the Middle East, the Gulf region, and North Africa, according to the KHCC’s Chairman, Dr. Hikmat Abdel-Razeq. And in two years, the facility will be able to treat even greater numbers of cancer patients.

By April 2016, an expansion plan will enable the KHCC to grow from 170 beds to approximately 400 beds.  Physicians will be able to see 7,000 unique cancer patients a year, more than double the 3,000 patients seen per year currently.

In addition, the modernization taking place at the center is mirrored by its workforce—95 percent of the KHCC staff are women, said Nadia.

She deemed the IMF’s first visit to Jordan a success.

“This meeting is just the start of a fruitful relationship, and a valuable collaboration,” she said.

Dr. Abdel-Razaq is looking forward to a great collaboration with the IMF, including patient/physician meetings, possibly in the fall of 2014.

Nadia made a prediction: “With the wonderful sense of solidarity the Jordanians share with their neighboring countries, I think the IMF’s outreach to the myeloma community can spread throughout the region. Working with the KHCC as a partner will certainly benefit the whole region.”

Standing from left: Dr. Sameer Yasser (KHCC); Dr. Maher Sughayrer (KHCC); Dr. Mohamad Hussein (Celgene); Nadia Elkebir (IMF); Dr. Hikmet Abdel-Razaq (Chairman of KHCC) 

Sitting from left: Mariam Michael (Pharmamed); Hanan Saab (Pharmamed); Rana Haddadin (Pharmamed); Dr. Amal Al Omari (KHCC)

The KHCC (King Hussein Cancer Center) 

King Abdullah II of Jordan and his son, Hussein bin Al Abdullah, Crown Prince of Jordan

Microbiology Lab at KHCC

Bone Marrow & Stem Cell Transplant Lab at KHCC

 


 related articles